Patricia Woertz - Procter Gamble Independent Director
| PG Stock | USD 155.45 0.12 0.08% |
Director
Ms. Patricia A. Woertz is Independent Director of the Company. Ms. Woertz is the former Chairman of the Board and Chief Executive Officer of Archer Daniels Midland Company, where she joined in 2006 as Chief Executive Officer and President and was named Chairman in 2007. Ms. Woertz retired as Chief Executive Officer of ADM in 2015 and as Chairman in 2016. Prior to joining ADM, Ms. Woertz was with Chevron Corporationration for 29 years and retired as EVP Global Downstream. She began her career as a certified public accountant with Ernst Ernst since 2008.
| Age | 67 |
| Tenure | 16 years |
| Professional Marks | CPA |
| Address | One Procter & Gamble Plaza, Cincinnati, OH, United States, 45202 |
| Phone | 513 983 1100 |
| Web | https://www.pginvestor.com |
Patricia Woertz Latest Insider Activity
Tracking and analyzing the buying and selling activities of Patricia Woertz against Procter Gamble stock is an integral part of due diligence when investing in Procter Gamble. Patricia Woertz insider activity provides valuable insight into whether Procter Gamble is net buyers or sellers over its current business cycle. Note, Procter Gamble insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procter Gamble'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Patricia Woertz over six months ago Acquisition by Patricia Woertz of 1520 shares of Procter Gamble subject to Rule 16b-3 | ||
Patricia Woertz over six months ago Acquisition by Patricia Woertz of 247 shares of Procter Gamble subject to Rule 16b-3 |
Procter Gamble Management Efficiency
The company has Return on Asset (ROA) of 0.1096 % which means that for every $100 of assets, it generated a profit of $0.1096. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.3178 %, which means that it produced $0.3178 on every 100 dollars invested by current stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.14. The current Return On Capital Employed is estimated to decrease to 0.20. At this time, Procter Gamble's Other Assets are most likely to increase significantly in the upcoming years. The Procter Gamble's current Asset Turnover is estimated to increase to 0.99, while Non Current Assets Total are projected to decrease to roughly 65.5 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Lynn Rothschild | Estee Lauder Companies | 66 | |
| Richard Zannino | Estee Lauder Companies | 61 | |
| John Rishton | Unilever PLC ADR | 63 | |
| Ann Fudge | Unilever PLC ADR | 67 | |
| Feike Sijbesma | Unilever PLC ADR | 62 | |
| Jack Stahl | Coty Inc | 61 | |
| Charlene Barshefsky | Estee Lauder Companies | 70 | |
| Adrian Hennah | Unilever PLC ADR | 63 | |
| Mariasun Larregui | Coty Inc | 57 | |
| Graeme Pitkethly | Unilever PLC ADR | 58 | |
| Louise Fresco | Unilever PLC ADR | 64 | |
| Jennifer Hyman | Estee Lauder Companies | 40 | |
| Kenneth Mitchell | ELF Beauty | 44 | |
| Fernando Fernandez | Unilever PLC ADR | 58 | |
| Sabrina Simmons | ELF Beauty | 57 | |
| Joachim Faber | Coty Inc | 67 | |
| Beth Pritchard | ELF Beauty | 73 | |
| Lauren Levitan | ELF Beauty | 54 | |
| Joseph Shamah | ELF Beauty | 34 | |
| Rose Bravo | Estee Lauder Companies | 69 | |
| Aerin Lauder | Estee Lauder Companies | 44 | |
Management Performance
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.11 |
Procter Gamble Leadership Team
Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kathleen Fish, Chief Research, Development and Innovation Officer | ||
| Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care | ||
| Matthew Janzaruk, Senior Officer | ||
| Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures | ||
| Kenneth Chenault, Independent Director | ||
| Debra Lee, Independent Director | ||
| Mindy Sherwood, President Global Walmart | ||
| Amy Chang, Independent Director | ||
| Nelson Peltz, Independent Director | ||
| Martin Riant, Group Pres and Advisor to the CEO | ||
| Hatsunori Kiriyama, President - Asia | ||
| Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations | ||
| Kirti Singh, Chief Analytics and Insights Officer | ||
| Tarek Farahat, President - Latin America | ||
| Francis Blake, Independent Director | ||
| Thomas Finn, President - Personal Health Care | ||
| Mohamed Samir, President - India, Middle East and Africa (IMEA) Selling and Market Operations | ||
| Alexandra Keith, President - Global Hair Care and Beauty Sector | ||
| Susan DesmondHellmann, Independent Director | ||
| Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader | ||
| Fama Francisco, Chief Executive Officer - Baby and Feminine Care | ||
| Loic Tassel, President - Europe | ||
| Margaret Whitman, Independent Director | ||
| Walter McNerney, Lead Independent Director | ||
| Terry Lundgren, Independent Director | ||
| Shelly McNamara, Senior Vice President of Human Resources | ||
| Angela Braly, Independent Director | ||
| Giovanni Ciserani, Group President of Global Fabric and Home Care and Global Baby and Feminine Care | ||
| M Grabowski, Chief Human Resource Officer | ||
| Victor Aguilar, Chief Research, Development and Innovation Officer | ||
| Damon Jones, Chief Officer | ||
| Javier Polit, Chief Information Officer | ||
| B Allen, Independent Director | ||
| James McNerney, Lead Independent Director | ||
| Ernesto Zedillo, Independent Director | ||
| Steven Bishop, Group President - Global Feminine and Family Care | ||
| Scott Cook, Independent Director | ||
| Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China | ||
| Sundar Raman, President - Fabric Care, North America and P&G Professional, Global | ||
| Ernesto Leon, Independent Director | ||
| Susan Whaley, Chief Secretary | ||
| R Keith, President - Global Hair Care and Beauty Sector | ||
| Ma Francisco, Chief Executive Officer - Baby and Feminine Care | ||
| Yannis Skoufalos, Global Product Supply Officer | ||
| Linda ClementHolmes, CIO | ||
| Jennifer Davis, President - Feminine Care | ||
| John Chevalier, Director - Investor Relations | ||
| Juan Posada, President - Latin America Selling and Market Operations | ||
| Fatima Francisco, Feminine Baby | ||
| Alan Lafley, Executive Chairman and Member of Proxy Committee | ||
| Jeffrey Schomburger, Global Sales Officer | ||
| Monica Turner, Senior Vice President - Sales, North America | ||
| Vittorio Cretella, Chief Information Officer | ||
| Christine McCarthy, Independent Director | ||
| Patricia Woertz, Independent Director | ||
| Shailesh Jejurikar, Chief Operating Officer, Chief Executive Officer - Fabric and Home Care | ||
| Philip Duncan, Chief Design Officer | ||
| Andre Schulten, Chief Financial Officer | ||
| Marc Pritchard, Global Brand Building Officer | ||
| Markus Strobel, President - Skin & Personal Care | ||
| David Taylor, Chairman of the Board, President, Chief Executive Officer | ||
| Mark Biegger, Global Human Resources Officer | ||
| Joseph Jimenez, Lead Independent Director | ||
| Matthew Price, President - Greater China Selling and Market Operations | ||
| Julio Nemeth, President - Global Business Services | ||
| Laura Becker, President - Global Business Services | ||
| Deborah Majoras, Chief Legal Officer, Secretary | ||
| Jon Moeller, Vice Chairman of the Board, President, Chief Executive Officer | ||
| Patrice Louvet, Group President - Global Beauty | ||
| Charles Pierce, Group President - Global Grooming | ||
| Gary Coombe, President - Europe Selling and Market Operations | ||
| Carolyn Tastad, Group President - North America Selling and Market Operations | ||
| Ken Patel, Chief Counsel |
Procter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 392.7 B | ||||
| Shares Outstanding | 2.35 B | ||||
| Shares Owned By Insiders | 0.09 % | ||||
| Shares Owned By Institutions | 67.57 % | ||||
| Number Of Shares Shorted | 16.91 M | ||||
| Price To Earning | 25.21 X |
Procter Gamble Investors Sentiment
The influence of Procter Gamble's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Procter. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Procter Gamble's public news can be used to forecast risks associated with an investment in Procter. The trend in average sentiment can be used to explain how an investor holding Procter can time the market purely based on public headlines and social activities around Procter Gamble. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Procter Gamble's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Procter Gamble's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Procter Gamble's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Procter Gamble.
Procter Gamble Implied Volatility | 38.99 |
Procter Gamble's implied volatility exposes the market's sentiment of Procter Gamble stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Procter Gamble's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Procter Gamble stock will not fluctuate a lot when Procter Gamble's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Procter Gamble in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Procter Gamble's short interest history, or implied volatility extrapolated from Procter Gamble options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procter Gamble using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Procter Stock analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Dividend Share 3.735 | Earnings Share 5.97 | Revenue Per Share 35.567 | Quarterly Revenue Growth 0.032 |
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.